Generac Holdings Inc. · GNRC · FY2026 Q3 · Calendar Q4 2026
Generac leans into data-center demand as backlog reaches $4.5 billion
Generac's supplied Q3 analysis supports the view that resilient data-center and residential demand can underpin growth, but the thesis depends on executing a major capacity ramp while managing engine supply, regulation, and customer concentration.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about GNRC FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the supplied prior-quarter analysis, the data-center opportunity expanded from a $1.6 billion backlog to a $4.5 billion backlog, supported by a long-term Amazon agreement. Management also described record Q3 sales, stronger residential growth, higher adjusted EBITDA margin guidance, and a plan to triple megawatt-generator output.
Guidance delta
Management raised adjusted EBITDA margin guidance and reaffirmed the full-year 2026 sales outlook; the supplied analysis does not specify the numerical changes.
Key takeaways
- Q3 sales were described as a record $1.29 billion, up 16% year over year, with adjusted EBITDA up 33% year over year.
- The Amazon agreement adds expected shipments and expands the data-center backlog, while management plans to triple megawatt-generator output.
- Residential sales grew 9%, and free cash flow was $130 million, supporting capacity investment and potential strategic M&A.
Management priorities
- Ramp large megawatt-generator production at Sussex and add vertical integration through Belvidere.
- Expand manufacturing capacity across North America, Europe, Asia, and Latin America.
- Integrate Allmand, develop next-generation home-standby products, and grow the Ecobee platform.
Follow GNRC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Overweight | Maintain | Oct 23, 2026 |
| Keybanc | Overweight | Sector Weight | Upgrade | Oct 8, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Stifel | Buy | Buy | Maintain | Sep 30, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Sep 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 18, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Sep 17, 2026 |
| Roth Capital | Neutral | Neutral | Maintain | Sep 17, 2026 |
| Needham | Buy | Buy | Maintain | Sep 17, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 17, 2026 |
| UBS | Buy | Buy | Maintain | Aug 4, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| Jefferies | Buy | Hold | Upgrade | May 22, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 1, 2026 |
| TD Cowen | Buy | Buy | Maintain | Apr 30, 2026 |
| Argus Research | Buy | Buy | Maintain | Apr 30, 2026 |
| B of A Securities | Buy | Buy | Maintain | Mar 26, 2026 |
| Guggenheim | Neutral | Buy | Downgrade | Feb 12, 2026 |
| Baird | Outperform | Neutral | Upgrade | Jan 9, 2026 |
| TD Securities | Buy | Buy | Maintain | May 1, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 13, 2025 |
| Truist Securities | Buy | Buy | Maintain | Jan 16, 2025 |
| Roth MKM | Neutral | Neutral | Maintain | Oct 22, 2024 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Aug 1, 2024 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Jul 29, 2024 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Jun 13, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | May 2, 2024 |
| OTR Global | Positive | Mixed | Upgrade | Apr 2, 2024 |
| William Blair | Outperform | Outperform | Maintain | Jul 6, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Sep 30, 2022 |
| Colliers Securities | Buy | Buy | Maintain | Dec 15, 2021 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Feb 12, 2021 |
| Bank of America | Neutral | Buy | Downgrade | Nov 1, 2019 |
| Northcoast Research | Buy | Neutral | Upgrade | May 3, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Aug 2, 2018 |
| SunTrust Robinson Humphrey | Buy | Hold | Upgrade | Feb 14, 2018 |
| Wolfe Research | Perform | Peer Perform | Maintain | Jul 11, 2017 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 12, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $201.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Dimple Gosai | $279 | $186.09 | +38.6% | Oct 23, 2026 |
| Piper Sandler | Dimple Gosai | $303 | $221.34 | +50.5% | Oct 8, 2026 |
| KeyBanc | Jeffrey Hammond | $280 | $221.34 | +39.1% | Oct 8, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $297 | $216.8 | +47.5% | Oct 5, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $290 | $212.22 | +44.0% | Sep 30, 2026 |
| Wells Fargo | Analyst unavailable | $280 | $207.23 | +39.1% | Sep 17, 2026 |
| Roth Capital | Analyst unavailable | $250 | $209.81 | +24.2% | Sep 17, 2026 |
| Raymond James | Tanner James | $286 | $175.11 | +42.0% | Sep 17, 2026 |
| Canaccord Genuity | Analyst unavailable | $375 | $175.11 | +86.3% | Sep 17, 2026 |
| HSBC | Analyst unavailable | $333 | $175.11 | +65.4% | Sep 17, 2026 |
| UBS | Analyst unavailable | $340 | $207.77 | +68.9% | Aug 4, 2026 |
| Roth Capital | Analyst unavailable | $214 | $192.3 | +6.3% | Jul 30, 2026 |
| D.A. Davidson | Analyst unavailable | $333 | $192.85 | +65.4% | Jul 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $333 | $196.07 | +65.4% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $305 | $191.26 | +51.5% | Jul 30, 2026 |
| Needham | Analyst unavailable | $283 | $195.19 | +40.6% | Jul 30, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $285 | $195.19 | +41.6% | Jul 30, 2026 |
| Barclays | Analyst unavailable | $278 | $195.19 | +38.1% | Jul 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $325 | $215.61 | +61.4% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $285 | $278.62 | +41.6% | Jun 29, 2026 |
| UBS | Analyst unavailable | $335 | $239.11 | +66.4% | Jun 11, 2026 |
| Jefferies | Analyst unavailable | $302 | $247.79 | +50.0% | May 22, 2026 |
| Raymond James | Tanner James | $302 | $247.79 | +50.0% | May 22, 2026 |
| UBS | Analyst unavailable | $305 | $263 | +51.5% | May 5, 2026 |
| Stephens | Analyst unavailable | $290 | $257 | +44.0% | May 1, 2026 |
| Roth Capital | Chip Moore | $257 | $254.23 | +27.6% | Apr 30, 2026 |
| Argus Research | John Eade | $290 | $257.78 | +44.0% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $275 | $256.29 | +36.6% | Apr 30, 2026 |
| Canaccord Genuity | Analyst unavailable | $325 | $252.92 | +61.4% | Apr 30, 2026 |
| Robert W. Baird | Analyst unavailable | $311 | $252.92 | +54.5% | Apr 30, 2026 |
| Barclays | Christine Cho | $228 | $194.4 | +13.2% | Mar 27, 2026 |
| UBS | Jon Windham | $270 | $215.04 | +34.1% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $213 | $223.72 | +5.8% | Feb 12, 2026 |
| Stifel Nicolaus | Analyst unavailable | $235 | $221.67 | +16.7% | Feb 12, 2026 |
| Roth Capital | Analyst unavailable | $220 | $214.99 | +9.3% | Feb 12, 2026 |
| Robert W. Baird | Michael Halloran | $292 | $214.99 | +45.0% | Feb 12, 2026 |
| Canaccord Genuity | Analyst unavailable | $275 | $214.99 | +36.6% | Feb 12, 2026 |
| Barclays | Analyst unavailable | $186 | $160.85 | -7.6% | Jan 20, 2026 |
| Canaccord Genuity | Analyst unavailable | $236 | $156.6 | +17.2% | Jan 13, 2026 |
| Robert W. Baird | Analyst unavailable | $199 | $148.79 | -1.2% | Jan 9, 2026 |
| Wells Fargo | Analyst unavailable | $195 | $136.99 | -3.1% | Dec 19, 2025 |
| Barclays | Analyst unavailable | $197 | $165.78 | -2.2% | Oct 31, 2025 |
| UBS | Analyst unavailable | $215 | $174.3 | +6.8% | Oct 30, 2025 |
| Roth Capital | Chip Moore | $184 | $180.86 | -8.6% | Oct 30, 2025 |
| Needham | Analyst unavailable | $248 | $183.96 | +23.2% | Oct 22, 2025 |
| Guggenheim | Analyst unavailable | $202 | $168.3 | +0.3% | Oct 9, 2025 |
| Barclays | Analyst unavailable | $188 | $165.67 | -6.6% | Oct 6, 2025 |
| Canaccord Genuity | Analyst unavailable | $240 | $164.26 | +19.2% | Sep 25, 2025 |
| UBS | Jon Windham | $220 | $181 | +9.3% | Jul 31, 2025 |
| Barclays | Analyst unavailable | $200 | $181 | -0.7% | Jul 30, 2025 |
| Stifel Nicolaus | Stephen Gengaro | $175 | $165.55 | -13.1% | Oct 31, 2024 |
| Truist Financial | Jordan Levy | $210 | $165.55 | +4.3% | Oct 31, 2024 |
| Goldman Sachs | Jerry Revich | $148 | $165.55 | -26.5% | Oct 31, 2024 |
| Citigroup | Vikram Bagri | $172 | $166.65 | -14.6% | Oct 21, 2024 |
| Piper Sandler | Kashy Harrison | $175 | $146.24 | -13.1% | Sep 24, 2024 |
| Canaccord Genuity | George Gianarikas | $200 | $155.68 | -0.7% | Aug 1, 2024 |
| Truist Financial | Jordan Levy | $170 | $147.8 | -15.6% | May 23, 2024 |
| Oppenheimer | Christopher Glynn | $145 | $127.63 | -28.0% | May 2, 2024 |
| Roth Capital | Chip Moore | $135 | $134.12 | -32.9% | Apr 23, 2024 |
| Canaccord Genuity | George Giankarikas | $150 | $131.34 | -25.5% | Apr 5, 2024 |
| CFRA | Strong Buy | $145 | $125.8 | -28.0% | Feb 7, 2024 |
| Truist Financial | Jordan Levy | $160 | $113.95 | -20.5% | Aug 4, 2023 |
| Canaccord Genuity | George Giankarikas | $175 | $135.54 | -13.1% | Feb 16, 2023 |
| Janney Montgomery | Sean Milligan | $160 | $91.15 | -20.5% | Dec 28, 2022 |
| Roth Capital | Philip Shen | $75 | $110.3 | -62.7% | Oct 20, 2022 |
| Compass Point | Mark Strouse | $461 | $249.79 | +129.0% | Jul 21, 2022 |
| Wells Fargo | Praneeth Satish | $285 | $213.05 | +41.6% | Jun 29, 2022 |
| J.P. Morgan | Mark Strouse | $455 | $259.5 | +126.0% | May 5, 2022 |
| J.P. Morgan | Mark Strouse | $469 | $316.44 | +132.9% | Feb 16, 2022 |
| Bank of America Securities | Ross Gilardi | $350 | $265.19 | +73.8% | Jan 26, 2022 |
| Truist Financial | Tristan Richardson | $425 | $286.19 | +111.1% | Jan 24, 2022 |
| UBS | Jon Windham | $480 | $323.73 | +138.4% | Jan 10, 2022 |
| Piper Sandler | Kashy Harrison | $481 | $316.55 | +138.9% | Jan 7, 2022 |
| Roth Capital | Philip Shen | $555 | $453.4 | +175.7% | Nov 3, 2021 |
| Guggenheim | Joseph Osha | $460 | $409.19 | +128.5% | Jun 28, 2021 |
Track every rating change on GNRC the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationGenerac Holdings Inc. specializes in the engineering, manufacturing, and global distribution of diverse power generation systems, energy storage solutions, and related electrical products. The company caters to residential users, light commercial enterprises, and industrial sectors worldwide. At its core, Generac produces vital components such as engines, alternators, batteries, advanced electronic controls, and robust steel enclosures. For homeowners, the company provides a range of automatic standby generators, from 7.5kW up to 150kW, including air-cooled models (7.5kW-26kW) and more powerful liquid-cooled units (22kW-150kW). Many of these residential systems are compatible with Mobile Link, a remote monitoring platform. Generac also offers portable generators, spanning outputs from 800W to 17.5kW, alongside an extensive catalog of outdoor power equipment like trimmers, mowers, log splitters, and pressure washers.…
Historical context
All GNRC earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FER Ferrovial N.V. | FY2026 Q3 · Calendar Q4 2026 | — | +7.3% | Ferrovial: Core infrastructure growth and new U.S. awards stand out |
| OTIS Otis Worldwide Corporation | FY2026 Q3 · Calendar Q4 2026 | — | -1.8% | Otis: Service momentum offsets continued China new-equipment weakness |
| ODFL Old Dominion Freight Line, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -6.2% | ODFL: Strong Q3 growth, with Q4 cost pressure in view |
| AER AerCap Holdings N.V. | FY2026 Q3 · Calendar Q4 2026 | — | +5.4% | AerCap raises full-year EPS guidance after record Q3 |
| GEV GE Vernova Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -1.4% | GE Vernova raises 2026 outlook as orders and margins accelerate |
| WM Waste Management, Inc. | FY2026 Q3 · Calendar Q4 2026 | -1.4% | -3.2% | WM reaffirms guidance as technology and pricing support margins |
Latest beats and misses
Who reports nextBeat on EPS
- ESSFY2026 Q3 · October 27, 2026+3.4% EPS-4.0% move
- ACGLFY2026 Q3 · October 27, 2026+15.6% EPS+1.8% move
- OKEFY2026 Q3 · October 27, 2026+42.0% EPS-1.6% move
- ACGLOFY2026 Q3 · October 27, 2026+15.6% EPS-0.2% move
- BXPFY2026 Q3 · October 27, 2026+40.9% EPS+1.7% move
- TERFY2026 Q3 · October 27, 2026+9.6% EPS-3.7% move
Get the GNRC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-28T16:11:07.879064+00:00
- FN2 earnings calendar · 2026-10-28T01:23:13.546025+00:00
- Polygon adjusted daily market bars · 2026-10-28T18:50:41.044173+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-28T18:50:41.041460+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-28. For educational purposes only; not investment advice.